China Sky One Medical, Inc. Donates RMB 1.1 Million in Medicine for Earthquake Disaster Relief Efforts
2008年5月30日 - 12:15AM
PRニュース・ワイアー (英語)
HARBIN, China, May 29 /Xinhua-PRNewswire-FirstCall/ -- China Sky
One Medical, Inc. (AMEX:CSY) ("China Sky One Medical", "CSY"), a
manufacturer, marketer and distributor of pharmaceutical, medicinal
and diagnostic products in China, today announced that it is
donating external-use medicine worth a total of RMB 1,115,300 to
Heilongjiang Foundation and Red Cross China for earthquake disaster
relief efforts. The management of China Sky One Medical has been
very concerned with the disaster relief efforts ever since the
earthquake struck Sichuan province on May 12, 2008. The earthquake
led to significant loss of life and property. "As an
entrepreneurial company, we have received a lot of support from the
people and the surrounding communities over the years. It is our
duty to do whatever we can to give back to the communities,
especially during this difficult time," said Mr. Yanqing Liu,
Chairman and CEO of China Sky One Medical. Since May 17th, all the
medicine donated by the Company has been delivered to regions
struck by the disaster by Heilongjiang Foundation and Red Cross
China. The donations consisted primarily of medicine for the
treatment of injuries due to contusion, sprains and fractures, the
most common problems observed among the earthquake victims. Since
its inception, the Company has operated under the principal of
"serving the people, managing with integrity." Over the years, the
Company, together with the surrounding communities, have faced and
overcome numerous challenges. The total value that China Sky One
Medical has donated to the communities since its founding is in
excess of RMB 5 million, for causes ranging from disaster relief
for the flood in 1998 to donations for the construction of schools,
to donations to alleviate poverty and care for the elderly. "We
feel a strong sense of responsibility and believe all Chinese
people should form a united front to combat the pain and suffering
following this natural disaster. Going forward, we will not only
donate medicine to help the victims in the regions affected by the
earthquake, but we will also send healthcare professionals to the
regions that were hit the hardest by earthquake and leverage our
new biotechnology test kits to perform early diagnosis on victims,"
concluded Mr. Liu. About China Sky One Medical, Inc. China Sky One
Medical, Inc., a Nevada corporation, is a holding company whose
principal operations are through its subsidiaries, which are
engaged in the manufacturing, marketing and distribution of
pharmaceutical, medicinal and diagnostic kit products. Through its
wholly-owned PRC based subsidiaries, Harbin Tian Di Ren Medical
Science and Technology Company Harbin First Bio- Engineering
Company Limited and Heilongjiang Tianlong Pharmaceutical, Inc., the
Company manufactures and distributes over-the-counter
pharmaceutical products as its primary revenue source. For more
information, visit http://www.skyonemedical.com/ . Safe Harbor
Statement Certain of the statements made in the press release
constitute forward- looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. These statements
can be identified by the use of forward- looking terminology such
as "believe," "expect," "may," "will," "should," "project," "plan,"
"seek," "intend," or "anticipate" or the negative thereof or
comparable terminology. Such statements typically involve risks and
uncertainties and may include financial projections or information
regarding our future plans, objectives or performance. Actual
results could differ materially from the expectations reflected in
such forward-looking statements as a result of a variety of
factors, including the inability of the company to meet the listing
standards, risks associated with the effect of changing economic
conditions in The People's Republic of China, variations in cash
flow, reliance on collaborative retail partners and on new product
development, variations in new product development, risks
associated with rapid technological change, and the potential of
introduced or undetected flaws and defects in products, and other
risk factors detailed in reports filed with the Securities and
Exchange. For more information, please contact: Company Contact:
China Sky One Medical, Inc. Mr. Liao Xiaoqing, CFO Phone:
+86-1591-067-2198 Email: Investor Relations Contact: CCG Elite
Investor Relations Inc. Mr. Crocker Coulson, President Phone:
+1-646-213-1915 (New York) Email: Web: http://www.ccgelite.com/
DATASOURCE: China Sky One Medical, Inc. CONTACT: Company Contact:
Mr. Liao Xiaoqing, CFO of China Sky One Medical, Inc.,
+86-1591-067-2198, or ; Or Investor Relations Contact: Mr. Crocker
Coulson, President of CCG Elite Investor Relations Inc.,
+1-646-213- 1915 (New York), or
Copyright
China Sky One Medicl (AMEX:CSY)
過去 株価チャート
から 12 2024 まで 1 2025
China Sky One Medicl (AMEX:CSY)
過去 株価チャート
から 1 2024 まで 1 2025